In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

Surveillance identified 7,381 candidemia cases, with an incidence of 7.4 cases per 100,000 people. Across age-groups, sexes, ...

Ethiopia has confirmed its first mpox cases, a 21-day old infant and the baby’s two parents, bringing the number of African ...

Despite being the leading cause of acute gastroenteritis  worldwide, there are currently no vaccines for norovirus.

Brazil has reported its first H5N1 avian flu outbreak in commercial poultry, which began on May 12 near the city of ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

Patients who received antiviral drugs were at significantly lower risk of the primary outcome than controls (hazard ratio [HR ...

Though measles activity continues to decline in a large outbreak centered in West Texas, other states continue to report a ...